3,5-dibromo-1-isobutyl-1H-1,2,4-triazole

Catalog No. :
ACRPUG942
CAS No. :
799269-66-2
Molecular Formula :
C6H9Br2N3
Molecular Weight :
280.92

IUPAC Name:3,5-dibromo-1-isobutyl-1H-1,2,4-triazole

3,5-dibromo-1-isobutyl-1H-1,2,4-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$57.00Login to see priceIn stockIn stock
250mg97%$100.00Login to see priceIn stockIn stock
1g97%$257.00Login to see priceIn stockIn stock
5g97%$1246.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-dibromo-1-isobutyl-1H-1,2,4-triazole
IUPAC Name3,5-dibromo-1-isobutyl-1H-1,2,4-triazole
MDL No.MFCD16811099
Molecular FormulaC6H9Br2N3
Molecular Weight280.92
SMILESBrC1=NN(CC(C)C)C(Br)=N1
InChI KeyOLZSOXYOAUGTLN-UHFFFAOYSA-N
Synonym1H-1,2,4-Triazole, 3,5-dibromo-1-(2-methylpropyl)-;3,5-dibromo-1-(2-methylpropyl)-1H-1,2,4-triazole;3,5-Dibromo-1-isobutyl-1H-1,2,4-triazole
CAS No.799269-66-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRPUG942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJIES258 route compound structure diagram
    ACJIES2587411-23-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPUG942 route product structure diagram
    ACRPUG942799269-66-2 In Stock
Inquiry

2. ACRPUG942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJIES258 route compound structure diagram
    ACJIES2587411-23-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPUG942 route product structure diagram
    ACRPUG942799269-66-2 In Stock
Inquiry

Comments (0)